Journal Key Facts
2.3
Journal Impact Factor
3.2
5-year-impact factor
Aims & Scope
Target Readership
Pharmacopsychiatry is intended for psychiatrists, neuroscientists, clinicians, and researchers working in the field of psychotropic drugs. It serves readers seeking key clinical insights as well as those interested in advances in psychopharmacology, biological psychiatry, neuroimaging, neurophysiology, and related neuroscientific disciplines.
Journal Purpose and Mission
The journal covers advances in the field of psychotropic drugs and provides psychiatrists, neuroscientists, and clinicians with key clinical insights while describing new avenues of research and treatment. It discusses the pharmacological and neurobiological bases of psychiatric disorders by presenting clinical and experimental research.
Types of Articles Published
Pharmacopsychiatry publishes the following article types, Original Paper, Review, Letter to the Editor, Editorial, and Commentary.
Publication Frequency
Publication Frequency
Pharmacopsychiatry publishes 6 issues per annum.
Subject and Content Scope
The journal’s content encompasses advances in psychotropic drugs, clinical insights, and emerging research and treatment approaches. It covers the pharmacological and neurobiological bases of psychiatric disorders through clinical and experimental research. Its subject areas include basic, translational, and clinical psychopharmacology; biological psychiatry; neuroimaging and neurophysiology; basic and clinical neurosciences; biological psychology; and pharmacogenetics.
Indexed In
- MEDLINE
- SCOPUS
- Science Citation Index
- EMBASE/Excerpta Medica
Fees & Licensing
Interested in this journal?
Submit your manuscript now or subscribe to this journal to always stay up to date.
Journal Information
Online ISSN
1439-0795
Print ISSN
0176-3679
DOI
10.1055/s-00000054
